Additionally, the liver of HFD fed mice and the treated hepatocytes exhibited impairment of insulin-signaling and glycogen synthesis, revealing miR-96 as a promoter of hepatic insulin resistance pathogenesis in obese states [45] (Figure 1A, Hepatocyte). This evidence concerns the gene INS and Insulin resistance.